Preoperative and postoperative cytokines in patients with cancer
Author:
Abstract
Background. Changes in tumor necrosis factor-alpha (TNF-α), interleukin-1 alpha (IL-1α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and granulocyte macrophage-colony-stimulating factor (GM-CSF) were investigated before and after operation in patients with hepatocellular carcinoma (HCC), metastatic liver carcinoma, and gastrointestinal carcinoma. Results. Serum levels of TNF-α, IL-1α, and IL-1β were high in patients with liver carcinoma (HCC and metastatic liver carcinoma) before operation in comparison with those of normal controls (P < 0.01). In patients with gastrointestinal carcinoma, serum levels of cytokines, except those of TNF-a, were the same as in patients with liver carcinoma. The level of TNF-α in patients with gastrointestinal carcinoma was low compared with that in patients with liver carcinoma. Within 1 day after operation, the peak level of TNF-a was observed at 15 hours, IL-1α at 18 hours, IL-1β at 21 hours, and IL-6 at 24 hours after operation. Subsequently, these cytokine levels peaked again: TNF-α at 48 hours, IL-1α at 72 hours, IL-1β at 120 hours, and IL-6 at 168 hours after operation. GM-CSF levels increased gradually after operation. Moreover, in HCC, serum levels of TNF-α were high in patients with recurrence compared with those without recurrence (P < 0.01). The difference in IL-1α and IL-1β levels between patients with recurrence and those without recurrence can be regarded as significant (P < 0.01). Conclusion. These results suggest that TNF-α, IL-1, IL-6, and GM-CSF may play an important role in the pathogenesis of cancers; TNF-α may be especially important as a tumor marker in HCC and metastatic liver carcinoma. Cancer 1992; 70:709–713.Keywords
This publication has 12 references indexed in Scilit:
- Cytokine regulation of human monocyte interleukin-1 (IL-1) productionin vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alphaClinical and Experimental Immunology, 1990
- Recombinant tumor necrosis factor enhances the proliferative responsiveness of murine peripheral macrophages to macrophage colony- stimulating factor but inhibits their proliferative responsiveness to granulocyte-macrophage colony-stimulating factorBlood, 1990
- The role of interleukin‐1 and tumour necrosis factor‐α in human multiple myelomaBritish Journal of Haematology, 1990
- The cytokine networkImmunology Today, 1989
- The biology of interleukin-6Blood, 1989
- Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operationClinical Immunology and Immunopathology, 1989
- Erythroid burst-promoting activity produced by interleukin-1-stimulated endothelial cells is granulocyte-macrophage colony-stimulating factorBlood, 1988
- Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation.Journal of Clinical Investigation, 1988
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.Journal of Experimental Medicine, 1986
- Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.Proceedings of the National Academy of Sciences, 1984